The various models of the Prius from Toyota Motor Corp. (NYSE: TM) are the best-selling hybrid vehicles in the United States. As of the end of July, the three versions of the car have sold nearly 140,000 units. And the carmaker is planning to make the car lighter and more fuel efficient for the 2015 model year.
The Prius has been available in the U.S. for more than 15 years, and Toyota�� leadership in hybrid car sales has never been threatened. According to HybridCars.com, 47 hybrid car models were available for sale in July, and Prius has garnered nearly 46% of all hybrid sales in the first seven months of the year. In the month of July, the aggregate market share for all Toyota hybrid models was just over 70%.
The pretenders are legion: the Fusion and C-Max hybrids from Ford Motor Co. (NYSE: F ) have sold more than 43,000 units so far this year, and the Malibu hybrid from General Motors Co. (NYSE: GM) has sold a little more than 12,000. The Civic hybrid from Honda Motor Co. Ltd. (NYSE: HMC) has sold an anemic 3,719 cars so far this year.
Hot Low Price Stocks To Own For 2015: Stein Mart Inc.(SMRT)
Stein Mart, Inc. operates retail stores that offer fashion merchandise for women and men in the United States. The company?s stores provide fashion apparel, accessories, shoes, and home fashions. As of April 19, 2011, it operated a chain of 263 retail stores. The company was founded in 1908 and is headquartered in Jacksonville, Florida.
Advisors' Opinion:- [By CRWE]
Stein Mart, Inc. (Nasdaq:SMRT) reported comparable store sales for the four-week period ended August 25, 2012 increased 5.6 percent. Total sales for the period were $79.0 million, an increase of 6.9 percent from $73.9 million in the same period in 2011.
- [By Reuters]
Joshua Lott/Getty Images NEW YORK -- Several major U.S. retailers posted disappointing sales for November after cautious shoppers pinched their pennies at the start of a shorter holiday season. Some of the companies that reported sales gains ramped up bargains to bring in shoppers who appeared hesitant to splurge. Costco Wholesale (COST) said Thursday that sales at stores open at least a year rose 2 percent, below the 3.3 percent increase analysts were looking for, according to Thomson Reuters. The warehouse club chain said consumer electronics sales fell. Same-store sales at L Brands (LTD), owner of the Victoria's Secret lingerie chain, also came in below expectations. Its drop of 5.5 percent was far deeper than the 1.1 percent decline analysts were projecting. Wall Street analysts are expecting 11 top retailers to report a 2.7 percent increase in same-store sales for November, according to Thomson Reuters. Excluding drugstore operators, which get two-thirds of revenue from prescriptions, that gain is estimated at 2.3 percent. Gap (GPS) will report its November sales after U.S. markets close. Retailers have been contending with low consumer confidence and the need to prod shoppers with bargains this holiday season, which has six fewer days because of a late Thanksgiving. The National Retail Federation on Sunday said U.S. shoppers had spent 2.9 percent less this year over the Thanksgiving weekend, the kickoff to the holiday season. The Conference Board, an industry group, said last week that U.S. consumer confidence fell in November after a sharp drop in October as Americans worried about their future jobs and earnings prospects. Earlier this week, J.C. Penney (JCP) reported a 10.1 percent comparable sales increase, partially reversing a disastrous decline in 2012, but the department store chain had to resort to aggressive bargains. The "environment will remain as competitive" through the holiday season, Chief Executive Officer Myron Ullman said. I
- [By Paul Ausick]
Stein Mart Inc. (NASDAQ: SMRT) reported a 3.8% rise in same-store sales for August, above the 3% estimate from Retail Metrics. In August of last year, sales rose 5.6%.
- [By David Trainer]
Unfortunately, FVL's holdings don't look likely to out-perform. 67% of its capital is in stocks with a Dangerous-or-worse rating. Only 12% of its assets are in Attractive-or-better rated stocks. Its holdings include recent Danger Zone picks Rite Aid (RAD), Citigroup (C), and Stein Mart (SMRT). FVL's holdings get their worst scores on valuation.
Top 10 Heal Care Stocks To Own Right Now: AngioDynamics Inc.(ANGO)
AngioDynamics, Inc. designs, develops, manufactures, and markets various therapeutic and diagnostic devices that enable interventional physicians to treat PVD, tumors, and other non-coronary diseases. The company operates in two divisions, Vascular and Oncology/Surgery. The Vascular division provides venous products, including VenaCure EVLT laser systems and Sotradecol; angiographic products and accessories comprising angiographic catheters, entry needles, guidewires, and fluid management products; percutaneous transluminal angioplasty dilation balloon catheters, such as WorkHorse, WorkHorse II, and Profiler to open blocked blood vessels and dialysis access sites; drainage products consisting of the total abscession general, biliary, and nephrostomy drainage catheters; and thrombolytic products that include pulsespray infusion and unifuse thrombolytic catheters, and speedlyser to deliver thrombolytic agents. It also offers micro access sets that provide interventional phys icians a smaller introducer system for minimally-invasive procedures; Benephit, a therapeutic approach to deliver drugs directly to the kidneys; and various dialysis catheters, which comprise DuraMax, Schon, Evenmore, Dura-Flow, SCHON XL, LifeJet, and Centros dialysis catheters. In addition, this division provides PICC products consisting of Morpheus CT PICC, Morpheus CT PICC insertion kits, and Morpheus smart PICC; port products and accessories, including Vortex, SmartPort, and LifeGuard; and central venous catheter products. The Oncology/Surgery division offers radiofrequency ablation, embolization, and nanoknife products. The company markets its products to interventional radiologists, vascular surgeons, and surgical oncologists through a direct sales force in the United States and through a combination of direct sales and distributor relationships internationally. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.
Advisors' Opinion:- [By Wallace Witkowski]
In other earnings reports, shares of AngioDynamics Inc. (ANGO) �rose 4.1% to $18.71 on moderate volume after the medical device maker reported adjusted fiscal second-quarter earnings of 14 cents a share on revenue of $88.6 million, while analysts expected 7 cents a share on revenue of $87.5 million. For fiscal 2014, AngioDynamics sees revenue of $349 million to $353 million, while analysts expect $350.7 million.
- [By Monica Gerson]
AngioDynamics (NASDAQ: ANGO) is projected to post its Q1 earnings at $0.03 per share on revenue of $82.54 million.
Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets
- [By Lauren Pollock]
AngioDynamics Inc.(ANGO) swung to a modest fiscal second-quarter loss but achieved break-even per-share results as the medical-device maker’s revenue improved more than expected, pushing shares up 6.5% to $19.15 premarket.
Top 10 Heal Care Stocks To Own Right Now: Organovo Holdings Inc (ONVO)
Organovo Holdings, Inc. (Organovo), formerly Real Estate Restoration & Rental, Inc., incorporated in 2007, is a development-stage company. The Company has developed and is commercializing a platform technology for the generation of three-dimensional (3D) human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. On December 28, 2011, Real Estate Restoration and Rental, Inc.�� (RERR) entered into an Agreement and Plan of Merger, pursuant to which RERR merged with its, wholly owned subsidiary, Organovo (Merger Sub). On February 8, 2012, the Company merged with and into Organovo Acquisition Corp. (Acquisition Corp.), a wholly owned subsidiary of Organovo, with the Company surviving the merger as a wholly owned subsidiary of Organovo Holdings (the Merger). As a result of the Merger, Organovo acquired the business of Organovo, Inc.
The Company has collaborative research agreements with Pfizer, Inc. (Pfizer) and United Therapeutic Corporation (Unither). As of March 31, 2012, it has five federal grants, including Small Business Innovation Research grants and developed the NovoGen MMX Bioprinter (its first-generation 3D bioprinter). The Company is engaged in the development of specific 3D human tissues to aid Pfizer in discovery of therapies in two areas of interest. In addition, in October 2011, it entered into a research agreement with Unither to establish and conduct a research program to discover treatments for pulmonary hypertension using its NovoGen MMX Bioprinter technology. Additionally, under the research agreement with Unither, the Company granted Unither an option to acquire from the Company a worldwide, royalty-bearing license in certain intellectual property created under the research agreement solely for use in the treatment or prevention of pulmonary hypertension and all other lung diseases.
The Company�� NovoGen MMX Bioprinter is an automate! d device that enables the fabrication of three-dimensional (3D) living tissues comprised of mammalian cells. A custom graphic user interface (GUI) facilitates the 3D design and execution of scripts that direct precision movement of the dispensing heads to deposit cellular building blocks (bio-ink) or supporting hydrogel. The Company is using a third party manufacturer, Invetech Pty., of Melbourne, Australia, to manufacture its NovoGen MMX Bioprinter. Its bioprinting technology and surrounding intellectual property and commercial rights serve as a platform for product generation across multiple markets that employ cell- and tissue-based products and services.
The Company competes with Organogenesis, Advanced BioHealing, Tengion, Genzyme, HumaCyte and Cytograft Tissue Engineering.
Advisors' Opinion:- [By Steve Symington]
To answer that question, remember what our fellow Fool Isaac Pino reminded us a few weeks ago:�high-end production 3-D printers from companies like 3D Systems, Stratasys (NASDAQ: SSYS ) , and ExOne (NASDAQ: XONE ) are capable of using dozens of materials to print infinitely more complicated items including shoes, saws, guitar bodies, and other functioning tools with moving parts.�Heck, 3-D bioprinting specialist�Organovo (NYSEMKT: ONVO ) is currently working feverishly on perfecting the process of designing and creating functional human tissue which -- putting inevitable regulatory hurdles for using the technology aside -- could obviously change the health care world as we know it.
- [By Roberto Pedone]
Organovo (ONVO) is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications. This stock closed up 8.5% to $5.21 in Thursday's trading session.
52-Week Range: $1.78-$8.50
Thursday's Volume: 2.88 million
Three-Month Average Volume: 1.78 millionFrom a technical perspective, ONVO ripped higher here back above its 50-day moving average of $4.88 with heavy upside volume. This stock has been downtrending badly for the last month, with shares plunging lower from its high of $8.50 to its recent low of $4.43. During that downtrend, shares of ONVO have been consistently making lower highs and lower lows, which is bearish technical price action. That said, shares of ONVO might be ready to see its downside volatility stop and reverse its downtrend and enter a new uptrend. The probability for that reverse in trend is supported by the high volume on Thursday.
Traders should now look for long-biased trades in ONVO as long as it's trending above its recent low at $4.33 and then once it sustains a move or close above $5.21 to $5.64 with volume that hits near or above 1.78 shares. If we get that move soon, then ONVO will set up to re-test or possibly take out its next major overhead resistance levels at $6.65 to $7.50.
Top 10 Heal Care Stocks To Own Right Now: Zhongpin Inc.(HOGS)
Zhongpin Inc. engages in the processing and distribution of meat and food products primarily in the People?s Republic of China. The company provides pork and pork products, such as chilled pork, frozen pork, hog by-products and variety meats, and prepared meats; and vegetable and fruit products, including asparagus, sweet corn, broccoli, mushrooms, lima beans, strawberries, and capsicums. It sells its products fast food companies, processing factories, school cafeterias, factory canteens, hotels, army bases, and government departments, as well as directly to retail outlets, including supermarkets. The company also exports its products to Europe, Hong Kong, and other countries in Asia. As of December 31, 2010, it operated 157 showcase stores, 1,072 branded stores, and 2,097 supermarket counter locations. The company is headquartered in Changge City, the People?s Republic of China.
Advisors' Opinion:- [By Dan Caplinger]
Obviously, the big news for Smithfield during the quarter came from Shuanghui International's offer to buy out the company for $34 per share. The $4.7 billion offer has raised some nationalistic concerns, as the Committee on Foreign Investment in the U.S. will have to approve the merger, but Smithfield CEO Larry Pope said last month when the deal was announced that it believes the deal won't have an effect on the company's operations. In fact, the combination of China's largest meat processor and the world's biggest pork producer could produce a formidable opponent to industry rivals. In particular, Chinese pork producer Zhongpin (NASDAQ: HOGS ) will inevitably find itself under pressure if the deal goes through, as Shuanghui puts itself in a stronger competitive position in the industry.
Top 10 Heal Care Stocks To Own Right Now: SP Bancorp Inc.(SPBC)
SP Bancorp, Inc. operates as the holding company for SharePlus Federal Bank that provides community banking products and services to individuals, families, and businesses in the United States. The company offers various deposit products, including noninterest-bearing and interest-bearing demand accounts, savings accounts, money market accounts, and certificates of deposit. Its loan portfolio includes residential mortgage loans secured by residential real estate; commercial real estate and home equity loans, including lines of credit and home improvement loans; consumer loans consisting primarily of automobile loans; and commercial business loans. The company also provides brokerage services for the purchase and sale of non-deposit investment and insurance products through a third-party brokerage arrangement. It provides its services through seven branches, four of which are located near the Bank's headquarters in Plano, Texas; two branches are located in Louisville, Kentuc ky; and one branch is located in Irvine, California. The company was founded in 2010 and is headquartered in Plano, Texas.
Advisors' Opinion:- [By Lisa Levin]
SP Bancorp (NASDAQ: SPBC) shares touched a new 52-week high of $28.90 after the company agreed to be acquired by Green Bancorp for $46.2 million in cash.
Top 10 Heal Care Stocks To Own Right Now: NovaDx Ventures Corp (NDX)
NovaDX Ventures Corp. (Novadx) is a Canada-based mining investment company, engaged in investing in the North American junior resource exploration and mining sector. In January, 2012 a higher capacity auger machine was delivered to the Rosa Mine. During August 2012, the Company sold the small auger and paid off the higher capacity auger machine. On October 16, 2012,the Company announced that it, along with Sandstorm, have entered into a Letter of Intent to acquire certain coal properties and assets located in Campbell and Scott Counties, Tennessee. The Company�� wholly owned subsidiary MCoal Corporation (MCoal) operates the Rosa mine located in Blount Count, Alabama, which produces coal for the metallurgical and activated carbon coal markets. In January 2013, Sandstorm Metals and Energy Ltd together with the Company acquired Mine 12, the Turley Rail Load-Out, and the Smokey Junction Preparation Plant located in Campbell and Scott Counties, Tennessee. Advisors' Opinion:- [By Jim Jubak]
However, in all fairness, shares of Qualcomm have indeed lagged the Nasdaq 100 (NDX) over the past year. But despite that fact, Qualcomm is still currently rated a buy by a large percentage of analysts who continue to follow the stock. As Hendershot points out, perhaps that is because ��ualcomm believes the company can generate double-digit compound average growth for revenues and earnings for, at least, the next five years.��/p>
Top 10 Heal Care Stocks To Own Right Now: Kansas City Southern (KSU)
Kansas City Southern, through its subsidiaries, engages primarily in the freight rail transportation business. It operates north/south rail between Kansas City, Missouri, and various ports along the Gulf of Mexico in Alabama, Louisiana, Mississippi, and Texas in the midwest and southeast regions of the United States. The company also operates direct rail passageway between Mexico City and Laredo in Texas, serving various Mexico?s industrial cities and 3 of its shipping ports; and a 157-mile rail line extending from Laredo, Texas to the port city of Corpus Christi, Texas, as well as owns the northern half of the rail bridge at Laredo, Texas. In addition, Kansas City Southern holds a concession to operate a 47-mile railroad located adjacent to the Panama Canal, as well as operates and promotes commuter and tourist passenger services. Further, the company operates a bulk materials handling facility with deep-water access to the Gulf of Mexico at Port Arthur, Texas that stores and transfers petroleum coke from rail cars to ships primarily for export; and a railroad wood tie treatment facility. It serves customers conducting business in various industries, including electric-generating utilities, chemical and petroleum products, industrial and consumer products, agriculture and mineral products, automotive products, and intermodal freight transportation. The company was formerly known as Kansas City Southern Industries, Inc. and changed its name to Kansas City Southern in 2002. Kansas City Southern was founded in 1962 and is based in Kansas City, Missouri.
Advisors' Opinion:- [By Doug Ehrman]
Kansas Southern (NYSE: KSU ) is reporting on Friday. The street expects Kansas Southern to report EPS of $0.88, a 17% bump on a revenue increase of 4.4% to $571.3 million. One of the primary catalysts for the increase is the shale oil boom that is most likely to shake up the industry. Where Union Pacific is benefiting from increased coal shipments, largely on the West Coast, Kansas Southern transports oil.
- [By Dimitra DeFotis]
Shares of International Game Technology (IGT) sank nearly 15% Friday to $15.04, the second worst performance among companies in the Standard & Poor’s 500 behind railroad Kansas City Southern (KSU). International Game Technology reported earnings Thursday that missed earnings estimates and said its full-year earnings would be at the bottom of its forecasted range.
- [By Sara Murphy]
CSX (NYSE: CSX ) and Kansas City Southern (NYSE: KSU ) are all over the eastern seaboard, and they're both getting skin in the game. CSX plans to spend $2.3 billion on wide-ranging expansion activities such as raising highway bridges, enlarging mountain tunnels, and clearing obstacles to make room for double-decker containers from the Midwest to the mid-Atlantic ports.
No comments:
Post a Comment